Moss B - Search Results

1

Vaccination of infant macaques with a recombinant modified vaccinia virus Ankara expressing the respiratory syncytial virus F and G genes does not predispose for immunopathology.

de Waal L, Wyatt LS, Yüksel S, van Amerongen G, Moss B, Niesters HG, Osterhaus AD, de Swart RL. de Waal L, et al. Among authors: moss b. Vaccine. 2004 Feb 25;22(8):923-6. doi: 10.1016/j.vaccine.2003.10.010. Vaccine. 2004. PMID: 15161069

2

Attenuation and immunogenicity in primates of vaccinia virus recombinants expressing human interleukin-2.

Flexner C, Moss B, London WT, Murphy BR. Flexner C, et al. Among authors: moss b. Vaccine. 1990 Feb;8(1):17-21. doi: 10.1016/0264-410x(90)90171-h. Vaccine. 1990. PMID: 2316280

3

Roles of vaccinia virus in the development of new vaccines.

Moss B, Fuerst TR, Flexner C, Hugin A. Moss B, et al. Vaccine. 1988 Apr;6(2):161-3. doi: 10.1016/s0264-410x(88)80021-5. Vaccine. 1988. PMID: 3291453 Review.

4

Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells.

Wyatt LS, Moss B, Rozenblatt S. Wyatt LS, et al. Among authors: moss b. Virology. 1995 Jun 20;210(1):202-5. doi: 10.1006/viro.1995.1332. Virology. 1995. PMID: 7793072 Free article.

5

A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus.

Sutter G, Wyatt LS, Foley PL, Bennink JR, Moss B. Sutter G, et al. Among authors: moss b. Vaccine. 1994 Aug;12(11):1032-40. doi: 10.1016/0264-410x(94)90341-7. Vaccine. 1994. PMID: 7975844

6

Removal of the cleavage site of recombinant feline immunodeficiency virus envelope protein facilitates incorporation of the surface glycoprotein in immune-stimulating complexes.

Rimmelzwaan GF, Siebelink KH, Huisman RC, Moss B, Francis MJ, Osterhaus AD. Rimmelzwaan GF, et al. Among authors: moss b. J Gen Virol. 1994 Aug;75 ( Pt 8):2097-102. doi: 10.1099/0022-1317-75-8-2097. J Gen Virol. 1994. PMID: 8046415

7

Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza.

Bender BS, Rowe CA, Taylor SF, Wyatt LS, Moss B, Small PA Jr. Bender BS, et al. Among authors: moss b. J Virol. 1996 Sep;70(9):6418-24. doi: 10.1128/JVI.70.9.6418-6424.1996. J Virol. 1996. PMID: 8709274 Free PMC article.

8

Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates.

Moss B, Carroll MW, Wyatt LS, Bennink JR, Hirsch VM, Goldstein S, Elkins WR, Fuerst TR, Lifson JD, Piatak M, Restifo NP, Overwijk W, Chamberlain R, Rosenberg SA, Sutter G. Moss B, et al. Adv Exp Med Biol. 1996;397:7-13. doi: 10.1007/978-1-4899-1382-1_2. Adv Exp Med Biol. 1996. PMID: 8718576 Free PMC article. Review.

9

Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model.

Wyatt LS, Shors ST, Murphy BR, Moss B. Wyatt LS, et al. Among authors: moss b. Vaccine. 1996 Oct;14(15):1451-8. doi: 10.1016/s0264-410x(96)00072-2. Vaccine. 1996. PMID: 8994321

10

Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model.

Carroll MW, Overwijk WW, Chamberlain RS, Rosenberg SA, Moss B, Restifo NP. Carroll MW, et al. Among authors: moss b. Vaccine. 1997 Mar;15(4):387-94. doi: 10.1016/s0264-410x(96)00195-8. Vaccine. 1997. PMID: 9141209 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,099 results

Search Page